AccessPak for HIV PEP Expanded with Kaletra and Kanjinti Injection
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Kanjinti Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Kanjinti
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-KANK-A
- AccessPak for HIV PEP Expanded with Kaletra-Kank-A Soft Brush
- AccessPak for HIV PEP Expanded with Kaletra-Kantrex
- AccessPak for HIV PEP Expanded with Kaletra-Kao-Paverin Caps
- AccessPak for HIV PEP Expanded with Kaletra-Kao-Tin Advanced Formula
- AccessPak for HIV PEP Expanded with Kaletra-Kaodene A-D
- Kanjinti Injection-AccessPak for HIV PEP Expanded with Viracept
- Kanjinti Injection-Accolate
- Kanjinti Injection-Accretropin
- Kanjinti Injection-Accucaine
- Kanjinti Injection-AccuHist Drops
- Kanjinti Injection-AccuHist PDX Drops